Project Grant HT94252510312
Award Date
5/1/25
Completion Date
4/30/29
Dollars Obligated
$542K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Oklahoma City, OK 73104, USA
Similar Awards
The University of Oklahoma Health Sciences Center was awarded a $1,144,000 federal Project Grant under the Military Medical Research and Development program (CFDA 12.420) by the Defense Health Agency. The grant, awarded on May 1, 2025, will fund research focused on developing a novel drug therapy that targets the ORP4 protein as a precision treatment for ovarian cancer. The research aims to transform healthcare for military service members and the broader public by investigating innovative...
The University of Oklahoma (OU) was awarded a $1,051,250 Project Grant from the Defense Health Agency to conduct research on the re-expression of miR-195 as a therapeutic strategy for chemoresistant ovarian cancer. This research falls under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform health care for service members and the American public. The project is scheduled to run from August 15, 2023, to August 14, 2027. As a public...
The University of Oklahoma Health Sciences Center was awarded an $864,781 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from April 1, 2023 to March 31, 2026 targeting DCLK1-driven chemoresistance in ovarian cancer. The goal aligns with the Military Medical Research and Development program's focus on innovative medical solutions for Service Members and the public through...
This $427,109 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at the University of Oklahoma Health Sciences Center to investigate targeting DCLK1-mediated glutamine addiction in chemoresistant ovarian cancer metastases. The two-year project, running from May 2025 to May 2027, aims to develop innovative strategies for preventing and treating advanced ovarian cancer by exploring the role of a...
The University of Oklahoma will provide research services under a $310,000 Project Grant award from the Defense Health Agency. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve health care for service members and the public. Specifically, the University will conduct research to identify protein motifs in the bacterial enzyme Cas9 that are essential for virulence. This work will help transform health care...
The University of Oklahoma Health Sciences Center Division has been awarded a $144,992 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from November 1, 2024 to October 31, 2026, will support advanced biomedical research focused on "Vascular Regulation of Immunosuppression in Glioblastoma." The funding will enable the university to conduct...
The University of Oklahoma's Health Sciences Center Division was awarded a $717,750 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to investigate one-carbon metabolic alterations to target pancreatic cancer cachexia. The research effort aims to develop new treatments and improve patient care for this condition, which is a major concern for service members and veterans. The three-year project will be conducted in Oklahoma City,...
The U.S. Department of Defense's Defense Health Agency awarded Oklahoma State University a $1,234,405 Block Grant under the Military Medical Research and Development program (CFDA 12.420) on June 1, 2024. The grant supports a multi-year research partnership to develop innovative biomedical solutions relevant to military personnel and the broader public. Through this funding, Oklahoma State University will conduct a comprehensive range of investigative projects across disciplines such as cancer...
The Defense Health Agency awarded a $386,250 Project Grant to the University of Nebraska Medical Center through the Military Medical Research and Development program (CFDA 12.420) to support research targeting the validation and inhibition of RHNO1 function in ovarian cancer. The two-year award beginning July 1, 2023 will fund preclinical research efforts to investigate medical solutions for ovarian cancer at the molecular level. As the parent organization, the Board of Regents of the University...
The University of Nebraska Medical Center (UNMC) was awarded a $927,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research titled "TARGETING FGFR4 SIGNALING TO OVERCOME CHEMORESISTANCE IN OVARIAN CANCER". The grant has an award date of July 1, 2024 and an ultimate completion date of June 30, 2028. UNMC, a leading institution in health sciences education, innovative research, and patient care, will...